The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The global non-therapeutic biomolecules market is experiencing robust growth, poised to escalate from $25.02 billion in 2022 to $27.91 billion in 2023, demonstrating a remarkable compound annual growth rate (CAGR) of 11.5%. Projections for 2027 indicate a market size of $41.26 billion, driven by a CAGR of 10.3%. This surge is attributed to the increasing prevalence of research and laboratory testing, shaping the market dynamics of non-therapeutic biomolecules.

Research and Laboratory Testing: A Driving Force

• Significance of Laboratory Testing: Laboratory testing is a critical medical procedure involving the analysis of blood, urine, or other substances to diagnose and monitor diseases, playing a pivotal role in treatment planning.
• Rapid Increase in Research: Research is a creative application of knowledge to produce new concepts, theories, and understandings. The National Center for Science and Engineering Statistics reported a $2.7 billion (3.3%) increase in research and development spending by academic institutions in 2020.
• Laboratory Testing Statistics: According to the American Association for Clinical Chemistry (AACC), over 200,000 certified laboratories execute almost 13 billion laboratory tests in the U.S. annually. These services constitute 2.3% of U.S. healthcare expenditures and two percent of Medicare expenditures.
• Market Implication: The surge in research and laboratory testing activities intensifies the demand for non-therapeutic biomolecules, particularly those enhancing test sensitivity and specificity.

Key Players Shaping the Market

• Industry Leaders: Merck Group, Bio-Synthesis Inc., Eurogentec, and a host of other major players are pivotal in steering the course of the non-therapeutic biomolecules market.
• Diverse Participation: Companies like Danaher Corporation, Thermo Fisher Scientific Inc., and Eurofins Scientific SE contribute to the diverse and competitive landscape.
• Strategic Landscape: The market is characterized by strategic moves and innovations aimed at enhancing product offerings and maintaining market positions.

Embracing Product Innovations: A Dominant Trend

• Focus on R&D: Companies are prioritizing research and development to drive product innovations, a key trend gaining prominence in the non-therapeutic biomolecules market.
• BASF SE and Caregen Partnership: In January 2022, BASF SE partnered with Caregen to introduce the Peptovitae™ series, leveraging liposome-encapsulation technology. This innovative series addresses a broad spectrum of skin concerns, from signs of aging to moisturizing, showcasing the versatility of non-therapeutic biomolecules.
• Liposomal Encapsulation: The Peptovitae™ series utilizes liposomal encapsulation, a technique employing fats to deliver essential vitamins or medications to specific body sections in tiny bubbles without affecting other body parts.

Market Segmentation

• By Trad Pharma: The non-therapeutic biomolecules market is segmented into Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, and Monoclonal Antibodies, offering a diverse array of biomolecules catering to different research and testing needs.
• By End User: Segmentation includes Research, Pharma, and In vitro diagnostics (IVD), reflecting the varied applications and end-user needs in the market.

Regional Dynamics: Asia-Pacific at the Helm

• Market Leadership: In 2022, Asia-Pacific emerged as the largest region in the non-therapeutic biomolecules market, underscoring the region’s prominence in shaping market trends.
• Anticipated Growth: The forecast period expects Asia-Pacific to maintain its status as the fastest-growing region, indicating a continuous surge in the market’s footprint.

Read More On The Non-Therapeutic Biomolecules Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Request for A Sample Of The Global Non-Therapeutic Biomolecules Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8769&type=smp

The Table Of Content For The Non-Therapeutic Biomolecules Market Include:
1. Non-Therapeutic Biomolecules Market Executive Summary
2. Non-Therapeutic Biomolecules Market Segments
3. Non-Therapeutic Biomolecules Market Size And Non-Therapeutic Biomolecules Market Growth Rate
4. Key Non-Therapeutic Biomolecules Market Trends
5. Major Non-Therapeutic Biomolecules Market Drivers
……
25. Key Mergers And Acquisitions In The Non-Therapeutic Biomolecules Market
26. Top Non-Therapeutic Biomolecules Companies
27. Non-Therapeutic Biomolecules Market Opportunities And Strategies
28. Non-Therapeutic Biomolecules Market, Conclusions And Recommendations
29. Appendix

The Non-Therapeutic Biomolecules Market Global Market Report 2023 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the non-therapeutic biomolecules market.

View More Reports Related To The Market –
In Vitro Diagnostics Global Market Report 2023
Renal Biomarkers Global Market Report 2023
Dermatitis Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model